Additionally, exploring the potential of integrating other biomarkers, such as those reflecting neuronal damage (NfL) or astroglial activation (GFAP) [38], along with electrophysiological parameters [39], could improve prediction and capture the dynamic evolution of delirium. The gene discussed is GFAP; the disease is delirium.